We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+8.14%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$4.09B
AUM Growth
+$2.61B
(+177%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
60.1%
Top 10 Holdings %
Top 10 Hldgs %
6.33%
Holding
2,105
New
963
Increased
487
Reduced
137
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$37.8M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$35.1M |
| 3 |
T-Mobile US
TMUS
|
+$30.4M |
| 4 |
Nu Holdings
NU
|
+$27.8M |
| 5 |
Consolidated Edison
ED
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$17M |
| 2 |
Marvell Technology
MRVL
|
+$16.2M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$16.1M |
| 4 |
ServiceNow
NOW
|
+$13.3M |
| 5 |
Walmart Inc
WMT
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.87% |
| 2 | Industrials | 14.69% |
| 3 | Financials | 14.36% |
| 4 | Healthcare | 12.68% |
| 5 | Consumer Discretionary | 12.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Vital Farms
VITL
$586M
| $233K | 0.01% |
+6,040
| New | +$204K |
|
1427
Pacer Trendpilot US Large Cap ETF
PTLC
$3.19B
| $232K | 0.01% |
+4,579
| New | +$224K |
|
|
MPT
1428
Medical Properties Trust
MPT
$2.84B
| $231K | 0.01% |
53,623
+34,415
| +179% | +$170K |
|
1429
CTS Corp
CTS
$1.76B
| $231K | 0.01% |
+5,419
| New | +$219K |
|
1430
LiveOne
LVO
$59.8M
| $230K | 0.01% |
+30,469
| New | +$226K |
|
1431
Cheesecake Factory
CAKE
$5.03B
| $230K | 0.01% |
+3,666
| New | +$195K |
|
1432
VirTra
VTSI
$33.1M
| $228K | 0.01% |
+32,307
| New | +$170K |
|
|
GPMT
1433
Granite Point Mortgage Trust
GPMT
$63.7M
| $227K | 0.01% |
+91,739
| New | +$206K |
|
1434
World Acceptance Corp
WRLD
$861M
| $226K | 0.01% |
+1,369
| New | +$195K |
|
1435
Columbia Sportswear
COLM
$3.25B
| $226K | 0.01% |
+3,692
| New | +$238K |
|
|
ORC
1436
Orchid Island Capital
ORC
$1.31B
| $224K | 0.01% |
31,926
+19,929
| +166% | +$138K |
|
1437
Eldorado Gold
EGO
$8.33B
| $224K | 0.01% |
10,993
-71
| -0.6% | -$1.38K |
|
1438
Driven Brands
DRVN
$2.47B
| $223K | 0.01% |
+12,709
| New | +$218K |
|
1439
Regencell Bioscience
RGC
$2.79B
| $222K | 0.01% |
+13,042
| New | +$159K |
|
1440
VanEck Gold Miners ETF
GDX
$22.5B
| $220K | 0.01% |
+4,228
| New | +$210K |
|
1441
Trinity Industries
TRN
$2.92B
| $220K | 0.01% |
+8,145
| New | +$210K |
|
1442
Shore Bancshares
SHBI
$820M
| $220K | 0.01% |
+13,979
| New | +$197K |
|
1443
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
| $219K | 0.01% |
+4,356
| New | +$215K |
|
1444
S&T Bancorp
STBA
$1.9B
| $219K | 0.01% |
+5,797
| New | +$212K |
|
|
HLVX
1445
DELISTED
HilleVax
HLVX
| $217K | 0.01% |
+109,153
| New | +$200K |
|
1446
Badger Meter
BMI
$3.87B
| $214K | 0.01% |
+875
| New | +$198K |
|
1447
Veeco
VECO
$2.62B
| $214K | 0.01% |
+10,523
| New | +$208K |
|
1448
Teva Pharmaceuticals
TEVA
$40.4B
| $212K | 0.01% |
12,676
-180,711
| -93% | -$2.92M |
|
1449
Lifetime Brands
LCUT
$192M
| $212K | 0.01% |
+41,555
| New | +$155K |
|
1450
iShares Global Infrastructure ETF
IGF
$10.9B
| $212K | 0.01% |
3,578
-10,286
| -74% | -$587K |
|
Similar funds
HSA
O
LFG
JIM
CTC
NL
BPWM
VT
Y-Intercept (HK)'s Q2 2025 Portfolio in Review
As of Q2 2025, Y-Intercept (HK) held 2,105 positions worth $4.09B, up 177% from $1.48B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Y-Intercept (HK) deployed $2.46B of net new capital in Q2 2025, opening 963 new positions and adding to 487 existing holdings. Its largest new stake was Nu Holdings: 2,319,643 shares worth $31.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Novo Nordisk, an estimated $16.1M trimmed.
- Y-Intercept (HK)'s largest Q2 2025 buy was Nu Holdings: 2,319,643 shares worth $31.8M.
- Y-Intercept (HK) added most to UnitedHealth in Q2 2025, an estimated $37.8M increase.
- Y-Intercept (HK)'s biggest Q2 2025 reduction was Novo Nordisk, cutting an estimated $16.1M.
- Y-Intercept (HK) fully exited Arista Networks in Q2 2025, selling an estimated $17M.
- Y-Intercept (HK)'s ten largest holdings make up 6.3% of its $4.09B portfolio in Q2 2025.
- Y-Intercept (HK) opened 963 new positions and closed 518 in Q2 2025.
- Y-Intercept (HK)'s portfolio value rose 177% quarter-over-quarter to $4.09B.
Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.